Open AccessA case of small-cell lung cancer harboring an epidermal growth factor receptor mutation that responded to epidermal growth factor receptor tyrosine kinase inhibitor treatment
Author(s) -
Chia-Wen Chang,
Chih We Wang,
Cheng Lung Hsu
Publication year - 2020
Publication title -
journal of cancer research and practice
Language(s) - English
Resource type - Journals
eISSN - 2589-0425
pISSN - 2311-3006
DOI - 10.4103/jcrp.jcrp_31_19
Subject(s) - afatinib , epidermal growth factor receptor , medicine , cancer research , tyrosine kinase , epidermal growth factor , lung cancer , tyrosine kinase inhibitor , growth factor receptor inhibitor , gefitinib , oncology , cancer , receptor